Literature DB >> 25891769

[Non-traumatic corneal perforations: Therapeutic modalities].

M Bouazza1, A Amine Bensemlali2, M Elbelhadji2, L Benhmidoune2, H El Kabli3, N El M'daghri4, M Soussi Abdallaoui5, K Zaghloul6, A Amraoui2.   

Abstract

INTRODUCTION: The treatment of non-traumatic perforations of the cornea is a real challenge for the choice of surgical technique as well as for management of the causal pathology. The goal of our study is to determine the anatomical and functional results of the management of non-traumatic perforation of the cornea in the absence of ready access to a corneal graft.
MATERIALS AND METHODS: This is a retrospective, non-comparative monocentric study of 23 consecutive cases diagnosed and treated between January 2011 and January 2013. We included 23 eyes with non-traumatic corneal perforation. Various surgical techniques were used depending on the size and location of the corneal perforation.
RESULTS: The predominant etiology of the corneal perforations in our series was corneal abscess, found in 30.4% of cases (7 eyes). A conjunctival flap was performed in 43.5% of cases (10 eyes) followed by tarsorrhaphy in 21.7% of cases (5 eyes), autologous corneal patch in 17.4% of cases (4 eyes), amniotic membrane in 13% of cases (3 eyes) and finally cyanoacrylate glue in one case. Mean follow-up was 12.4 ± 2.1 months. Anatomical closure of the corneal perforation was achieved in 91.3% of cases (21 eyes), while the final visual acuity was not improved due to secondary opacities. DISCUSSION: The choice of surgical technique depends on the size of the corneal perforation, its location, its etiology and the resources available for emergencies. When amniotic membrane and corneal donor tissue are unavailable, conjunctival flap is an easy and effective technique, which is a good alternative to close corneal perforations less than 3mm. It improves ocular surface quality and prepares the eye for later penetrating keratoplasty.
CONCLUSION: Conjunctival flap is a good technique that is still relevant today, especially in the absence of corneal donor tissue or amniotic membrane. The anatomical success rate is very satisfactory, but sometimes several interventions are needed to improve the visual prognosis.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Abcès de cornée; Autologous corneal patch; Conjunctival flap; Corneal abscess; Corneal perforation; Non traumatique; Non-traumatic; Patch cornéen autologue; Perforation cornéenne; Recouvrement conjonctival

Mesh:

Year:  2015        PMID: 25891769     DOI: 10.1016/j.jfo.2014.11.012

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  5 in total

1.  Management of a central corneal perforation in the emergency room: Tenon patch technique.

Authors:  Moctar Issiaka; Meryem Bellamine; Adil Mchachi; Leila Benhmidoune; Rayad Rachid; Mohamed El Belhadji
Journal:  Int J Surg Case Rep       Date:  2022-04-26

2.  Differences in Surgical Management of Corneal Perforations, Measured over Six Years.

Authors:  Katarzyna Krysik; Dariusz Dobrowolski; Anita Lyssek-Boron; Judyta Jankowska-Szmul; Edward A Wylegala
Journal:  J Ophthalmol       Date:  2017-02-23       Impact factor: 1.909

3.  [Unusual complication of radiation therapy, corneal perforation: about a case].

Authors:  Taha Elghazi; Youssef Omor; Zouheir Hafidi; Amine Eljai; Zakaria Elmoize; Mohammed Afif; Abdellah Amazouzi; Lalla Ouafae Cherkaoui; Rajae Daoudi
Journal:  Pan Afr Med J       Date:  2016-10-03

4.  Total Penetrating Keratoplasty: Indications, Therapeutic Approach, and Long-Term Follow-Up.

Authors:  Katarzyna Krysik; Ewa Wroblewska-Czajka; Anita Lyssek-Boron; Edward A Wylegala; Dariusz Dobrowolski
Journal:  J Ophthalmol       Date:  2018-04-19       Impact factor: 1.909

5.  Amniotic Membrane as a Main Component in Treatments Supporting Healing and Patch Grafts in Corneal Melting and Perforations.

Authors:  Katarzyna Krysik; Dariusz Dobrowolski; Edward Wylegala; Anita Lyssek-Boron
Journal:  J Ophthalmol       Date:  2020-02-14       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.